Annovis Stock Story

ANVS -  USA Stock  

USD 9.72  0.30  3.18%

Annovis Stock News module provides quick insight into current market opportunities from investing in Annovis Bio. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Annovis Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Annovis Bio Hype Analysis, Annovis Bio Correlation and Annovis Bio Performance.
  
Refresh
Annovis Bio stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Annovis daily returns and investor perception about the current pice of Annovis Bio as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Maria Maccecchini of 32959 shares of Annovis Bio subject to Rule 16b-3
Filed transaction by Annovis Bio Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Annovis insider trading alert for exercise of stock option (right to buy) by Maria Maccecchini, President and CEO, on 18th of January 2022. This event was filed by Annovis Bio Inc with SEC on 2022-01-18. Statement of changes in beneficial ownership - SEC Form 4. Maria Maccecchini currently serves as president, chief executive officer, founder, director of Annovis Bio

Cash Floor Correlation

Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Annovis Bio Fundamental Analysis

We analyze Annovis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annovis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annovis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Peers

Your Trending Equities

ACRHF  4.00   
0%
100.0%
JLKLX  2.70   
0%
67.0%
NIO  2.66   
0%
66.0%
INMB  1.55   
0%
38.0%
SMNEY  1.06   
0%
26.0%
BCGPX  0.08   
0%
1.0%
TAXI  0.00   
0%
0%
HAR  0.00   
0%
0%
SSS  0.00   
0%
0%
GDI  0.00   
0%
0%
PPCCF  0.00   
0%
0%
DPS  0.00   
0%
0%
IWB  0.1   
2.0%
0%
SSNC  0.20   
5.0%
0%
LGV  0.20   
5.0%
0%
AQNA  0.35   
8.0%
0%
PRFT  2.88   
72.0%
0%
SONO  3.05   
76.0%
0%
PANW  3.42   
85.0%
0%
Please continue to Annovis Bio Hype Analysis, Annovis Bio Correlation and Annovis Bio Performance. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.